Market Closed -
Nasdaq
04:30:00 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
3.73
USD
|
-5.08%
|
|
-5.09%
|
+37.64%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
11.8
|
37.37
|
43
|
8.068
|
3.469
|
5.918
|
-
|
-
|
Enterprise Value (EV)
1 |
11.8
|
37.37
|
35.79
|
8.068
|
3.469
|
5.918
|
5.918
|
5.918
|
P/E ratio
|
-0.36
x
|
-0.96
x
|
-1.97
x
|
-0.25
x
|
-0.12
x
|
-1.79
x
|
-2.76
x
|
-4.34
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.29
x
|
4.27
x
|
4.25
x
|
-
|
0.45
x
|
0.56
x
|
0.42
x
|
0.33
x
|
EV / Revenue
|
1.29
x
|
4.27
x
|
4.25
x
|
-
|
0.45
x
|
0.56
x
|
0.42
x
|
0.33
x
|
EV / EBITDA
|
-
|
-2,492,604
x
|
-2,622,336
x
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-2,733,690
x
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-0%
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
4.42
x
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
34.5
|
283
|
319
|
496
|
1,280
|
1,586
|
-
|
-
|
Reference price
2 |
342.0
|
132.0
|
135.0
|
16.27
|
2.710
|
3.730
|
3.730
|
3.730
|
Announcement Date
|
3/5/20
|
3/11/21
|
3/22/22
|
3/15/23
|
3/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
9.131
|
8.761
|
10.13
|
-
|
7.652
|
10.5
|
13.93
|
17.8
|
EBITDA
|
-
|
-14.99
|
-16.4
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-19.36
|
-17.4
|
-18.1
|
-
|
-16.64
|
-16.28
|
-14.26
|
-12.27
|
Operating Margin
|
-212.01%
|
-198.65%
|
-178.69%
|
-
|
-217.39%
|
-155.07%
|
-102.37%
|
-68.9%
|
Earnings before Tax (EBT)
1 |
-19.45
|
-19.01
|
-17.41
|
-
|
-18.32
|
-16.28
|
-14.26
|
-12.27
|
Net income
1 |
-23.03
|
-22.87
|
-21.59
|
-27.24
|
-18.32
|
-16.28
|
-14.26
|
-12.27
|
Net margin
|
-252.22%
|
-261.07%
|
-213.1%
|
-
|
-239.41%
|
-155.07%
|
-102.37%
|
-68.9%
|
EPS
2 |
-954.0
|
-138.0
|
-68.55
|
-65.40
|
-23.31
|
-2.080
|
-1.350
|
-0.8600
|
Free Cash Flow
|
-
|
-
|
-15.73
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-155.29%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/5/20
|
3/11/21
|
3/22/22
|
3/15/23
|
3/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
2.366
|
2.403
|
1.888
|
2.132
|
1.888
|
2.041
|
1.817
|
1.906
|
2.36
|
2.551
|
2.726
|
2.859
|
3.1
|
EBITDA
|
-4.092
|
-4.339
|
-4.629
|
-3.659
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-4.489
|
-4.556
|
-4.696
|
-3.759
|
-
|
-
|
-4.033
|
-4.615
|
-4.498
|
-4.038
|
-3.921
|
-3.819
|
-
|
Operating Margin
|
-189.73%
|
-189.6%
|
-248.73%
|
-176.31%
|
-
|
-
|
-221.96%
|
-242.13%
|
-190.59%
|
-158.29%
|
-143.84%
|
-133.58%
|
-
|
Earnings before Tax (EBT)
1 |
-4.912
|
-4.996
|
-5.14
|
-4.214
|
-
|
-
|
-4.476
|
-5.024
|
-4.498
|
-4.038
|
-3.921
|
-3.819
|
-
|
Net income
1 |
-5.956
|
-6.039
|
-11.38
|
-5.341
|
-
|
-
|
-2.04
|
-5.024
|
-4.498
|
-4.038
|
-3.921
|
-3.819
|
-
|
Net margin
|
-251.73%
|
-251.31%
|
-602.65%
|
-250.52%
|
-
|
-
|
-112.27%
|
-263.59%
|
-190.59%
|
-158.29%
|
-143.84%
|
-133.58%
|
-
|
EPS
2 |
-18.00
|
-18.90
|
-34.95
|
-14.10
|
-10.65
|
-8.850
|
-2.920
|
-3.930
|
-1.350
|
-0.4300
|
-0.4200
|
0.1300
|
-0.4000
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/11/21
|
3/22/22
|
5/10/22
|
8/11/22
|
5/10/23
|
7/27/23
|
10/26/23
|
3/20/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
7.21
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-15.7
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
30.50
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
0.09
|
-
|
0.03
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
0.96%
|
-
|
0.34%
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/5/20
|
3/11/21
|
3/22/22
|
3/15/23
|
3/20/24
|
-
|
-
|
-
|
Last Close Price
3.73
USD Average target price
5
USD Spread / Average Target +34.04% Consensus |
1st Jan change
|
Capi.
|
---|
| +37.64% | 5.92M | | -5.77% | 14.68B | | -40.71% | 2.71B | | -12.92% | 2.44B | | -8.78% | 1.51B | | -.--% | 1.12B | | +40.66% | 518M | | +91.79% | 502M | | +1.67% | 183M | | -.--% | 168M |
Medical Imaging Systems
|